Duality Advisers, LP
- SEC CIK
- 0001741024
- Latest filing
- Nov 14, 2025
BBIO holding history
BridgeBio Pharma, Inc. in every 13F filed by Duality Advisers, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BBIO overviewAll 13F holders of BBIOFull Q3 2025 holdings
- Shares (Q2 2024)
- 0
- Sold out in Q2 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2024 | 0 | $0 | 0.0% | −73,679−100.0% | Sold out | Holders |
| Q1 2024 | 73,679 | $2.28M | 0.2% | −6,513−8.1% | Reduced | Holders |
| Q4 2023 | 80,192 | $3.24M | 0.3% | +31,036+63.1% | Added | Holders |
| Q3 2023 | 49,156 | $1.30M | 0.2% | +49,156 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −41,972−100.0% | Sold out | Holders |
| Q1 2023 | 41,972 | $695.9K | 0.1% | +41,972 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −216,254−100.0% | Sold out | Holders |
| Q4 2021 | 216,254 | $3.61M | 0.4% | +180,298+501.4% | Added | Holders |
| Q3 2021 | 35,956 | $1.69M | 0.1% | +10,174+39.5% | Added | Holders |
| Q2 2021 | 25,782 | $1.57M | 0.1% | +25,782 | New | Holders |